PureTech Health takeover talks with Nektar Therapeutics end

(Alliance News) - PureTech Health PLC on Tuesday said takeover talks with San Francisco-based ...

Alliance News 11 October, 2022 | 8:00AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - PureTech Health PLC on Tuesday said takeover talks with San Francisco-based biopharmaceutical company Nektar Therapeutics have been terminated.

PureTech on Friday had announced that it was in discussions to be acquired by Nektar. The talks were not as advanced as they seemed, however, PureTech said.

"These discussions were early in nature and the required announcement created the impression that discussions were more advanced than they were. Given the early stage of the discussions and the potential for an extended period of uncertainty, these discussions were terminated," the company explained.

PureTech added that it remains in an offer period until November 3 under regulatory rules.

Nektar gave consent to PureTech for publicising the termination but gave no further details.

PureTech Health shares were 2.2% lower at 223.50 pence each in London on Tuesday morning.

By Tom Budszus; tombudszus@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
PureTech Health PLC 222.50 GBX 0.00 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures